Peterson Thomas III 4
4 · Evolent Health, Inc. · Filed Sep 14, 2018
Insider Transaction Report
Form 4
Peterson Thomas III
Chief Operating Officer
Transactions
- Exercise/Conversion
Class A Common Stock Option (Right to buy)
2018-09-13−70,000→ 108,274 totalExercise: $3.84Exp: 2024-04-01→ Class A Common Stock (70,000 underlying) - Exercise/Conversion
Class A Common Stock
2018-09-13$3.84/sh+70,000$268,800→ 137,868 total - Sale
Class A Common Stock
2018-09-13$27.50/sh−70,000$1,925,000→ 67,868 total
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018.
- [F2]Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F3]The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $27.50-$27.55, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The Class A Common Stock Options exercised vested on December 1, 2014 and December 1, 2015.